U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
ANETUMAB RAVTANSINE
M170940PMI
Investigational
General
Names
8
Classification
4
Identifiers
8
Subunits
4
Related Substances
1
ANETUMAB RAVTANSINE
M170940PMI
Investigational
General
Approval Year
Unknown
149,124
Names
8
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
ANETUMAB RAVTANSINE
Official Name
English
BAY 94-9343
Preferred Name
English
BAY-94-9343
Code
English
BAY949343
Code
English
BAY94-9343
Code
English
Showing 1 to 5 of 8 entries
Previous
1
2
Next
Classification
4
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Positive
EU ORPHAN DRUG
Positive
Treatment of ovarian cancer
EU-Orphan Drug
EU/3/18/2084
Biological Agent
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Immunoconjugate
NCI_THESAURUS
C1512
Designated/Withdrawn
ORPHAN DRUG
Designated/Withdrawn
Treatment of mesothelioma
FDA ORPHAN DRUG
370112
Antineoplastic Biological Agent
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Antineoplastic Biological Agent
[C129821]
Antineoplastic Antibody-Drug Conjugate
NCI_THESAURUS
C129823
Showing 1 to 4 of 4 entries
Previous
1
Next
Identifiers
8
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
FDA UNII
M170940PMI
PRIMARY
NCI_THESAURUS
C98293
PRIMARY
CAS
1375258-01-7
PRIMARY
INN
9788
PRIMARY
DRUG BANK
DB14809
PRIMARY
Showing 1 to 5 of 8 entries
Previous
1
2
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
M170940PMI
ANETUMAB RAVTANSINE